Search Results - "Sennitt, Matthew"
-
1
Effect of high-fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 mice
Published in Proteomics (Weinheim) (01-08-2004)“…In the present study, the effect of a high fat diet on the expression of proteins in insulin target tissues was analyzed using a proteomic approach…”
Get full text
Journal Article -
2
Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: possible involvement of PPAR activation
Published in Lipids in health and disease (10-01-2005)“…Studies in rodents and some studies in humans have shown that conjugated linoleic acid (CLA), especially its trans-10, cis-12 isomer, reduces body fat content…”
Get full text
Journal Article -
3
Effect of Rosiglitazone on the Differential Expression of Diabetes-associated Proteins in Pancreatic Islets of C57Bl/6 lep/lep Mice
Published in Molecular & cellular proteomics (01-07-2002)“…The insulin sensitizer drug, rosiglitazone, has been shown to have a protective effect on pancreatic islet cell structure and function in animal models of type…”
Get full text
Journal Article -
4
The mouse SWISS-2D PAGE database: a tool for proteomics study of diabetes and obesity
Published in Proteomics (Weinheim) (01-01-2001)“…A number of two‐dimensional electrophoresis (2‐DE) reference maps from mouse samples have been established and could be accessed through the internet. An…”
Get full text
Journal Article -
5
Effect of rosiglitazone on the differential expression of obesity and insulin resistance associated proteins in lep/lep mice
Published in Proteomics (Weinheim) (01-08-2003)“…Peroxisome proliferator‐activated receptors (PPARs) participate in the molecular mechanism of pathologies with altered lipid homeostasis such as type 2…”
Get full text
Journal Article -
6
The effects of rexinoids and rosiglitazone on body weight and uncoupling protein isoform expression in the Zucker fa/fa rat
Published in Metabolism, clinical and experimental (01-12-2000)“…Agonists for the retinoid X receptor (RXR), the rexinoids, and the peroxisome proliferator-activated receptor gamma (PPAR γ), the thiazolidinediones, are…”
Get full text
Journal Article -
7
Antihyperglycemic Effects of Novel Long- and Short-Acting Glucokinase Activators (PSN105 and PSN010) in Diabetic Animals
Published in Diabetes (New York, N.Y.) (01-06-2005)Get full text
Journal Article -
8
Effect of Rosiglitazone on the Differential Expression of Diabetes Associated Proteins in Pancreatic Islets of C57B1/6J lep/lep Mice
Published in Diabetes (New York, N.Y.) (01-05-2000)Get full text
Journal Article -
9
BRL 35135, a potent and selective atypical β-adrenoceptor agonist
Published in The American journal of clinical nutrition (01-01-1992)“…BRL 35135, via its active deesterified metabolite BRL 37344, is a potent example of a new group of β-adrenoceptor agonists that stimulate selectively a novel β…”
Get full text
Journal Article Conference Proceeding -
10
The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL 37344
Published in The Journal of pharmacology and experimental therapeutics (01-04-1996)“…The stimulation by BRL 37344 of lipolysis in rat adipose tissues, and of relaxation of the rat distal colon, is mediated by the beta-3 adrenoceptor. The…”
Get more information
Journal Article -
11
The rat lipolytic beta-adrenoceptor: studies using novel beta-adrenoceptor agonists
Published in European journal of pharmacology (04-05-1984)“…EC50 and relative intrinsic activity values were obtained for isoprenaline, fenoterol, salbutamol, prenalterol and three new beta-adrenoceptor agonists, BRL…”
Get more information
Journal Article -
12
Anti-hyperglycaemic action of BRL 26830, a novel beta-adrenoceptor agonist, in mice and rats
Published in Biochemical pharmacology (15-04-1985)“…BRL 26830, (R*,R*)-(+/-)-methyl 4-[2-[(2-hydroxy-2-phenylethyl)amino] propyl] benzoate, is a new orally active anti-hyperglycaemic agent. In 24 hr-fasted rats…”
Get more information
Journal Article -
13
Effects of BRL 26830, a novel beta-adrenoceptor agonist, on glucose tolerance, insulin sensitivity and glucose turnover in Zucker (fa/fa) rats
Published in Biochemical pharmacology (15-07-1985)“…Zucker fa/fa rats exhibit glucose intolerance in comparison with lean Fa/? littermates. A single acute dose of BRL 26830 (2.9 mg/kg p.o.) improved glucose…”
Get more information
Journal Article -
14
Effect of a novel thermogenic beta-adrenoceptor agonist (BRL 26830) on insulin resistance in soleus muscle from obese Zucker rats
Published in Biochemical and biophysical research communications (30-04-1985)“…Young lean (Fa/?) and obese (fa/fa) rats were treated with the thermogenic beta-adrenoceptor agonist, BRL 26830, for 3 weeks. In lean rats this treatment had…”
Get more information
Journal Article